Hospital Ramos Mejia

Buenos Aires C1221ADC

0 studies enrolling now · 4 studies all time

What they study most

Cerebroside Lipidosis Syndrome, Covid19, Focal Onset Seizures, Gaucher Disease, Non-Neuronopathic Form, Gaucher Disease, Type 1, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

Studies at this site

• A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3) — Recruiting now
• Immune Modulators for Treating COVID-19 — Completed
• A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients — Completed
• Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) — Completed